ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028

Lifesciences | Healthcare IT

ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028

Market by Phase Type, Service, Sponsor, and Country Outlook | Forecast 2022-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s report, the clinical trials support services market in the Asia-Pacific is likely to advance with a CAGR of 8.41% in the estimated period from 2022 to 2028.



Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in this region include:

•         South Korea

•         ASEAN Countries

•         India

•         Japan

•         Australia & New Zealand

•         China

•         Rest of Asia-Pacific

China accounted for the largest share of the Asia-Pacific market in 2021. The high prevalence of certain diseases in some Asian countries makes them preferred sites for the treatment trials of those diseases. Pharmaceutical companies, for instance, are more likely to conduct drug trials for treating gastroesophageal cancer or liver cancer in China or Korea, respectively, because these nations have a large pool of patients affected by these ailments.

China provides lucrative opportunities for conducting clinical trials, owing to its vast population. Owing to this, there are a number of research experts and other professionals required to efficiently conduct trials available, along with a large patient pool. Moreover, government regulations are also favorable, which aids in conducting clinical trials. China is now focusing on increasing the number of clinical trials conducted each year. These factors are indicative of the clinical trials support services market’s growth in the country, over the coming years.

South Korea has emerged as an attractive destination for conducting clinical trials owing to the availability of clinical experts, a robust infrastructure, a dense population, favorable government regulations, etc. The nation has an added advantage along with access to a larger population, i.e., its aging population is higher than its young population. Another advantage is the similar disease patterns and unmet medical needs of the Korean population compared to those in western countries. All these advantages attract pharmaceutical companies and other organizations in this field to conduct their clinical trials in the country, thus bolstering the market’s growth. 

Some of the data management activities include data collection; data entry & validation; case report form (CRF) design, annotation, & tracking; data storage & privacy, database designing, building, & testing; and others. There are several solutions available for clinical trial data management. Some of the examples of these solutions include the EXPERT Platform by ERT, which offers clinical trial management software consisting of data management & security and compliance monitoring services.

Triton’s report assesses the market based on service, sponsor, and phase type. Here, the service segment comprises data management, administrative services, clinical trial site management, regulatory services, patient recruitment management, and other services.

The notable companies in the clinical trials support services market are Advanced Clinical, Clinipace, ICON Plc, Labcorp Drug Development, Charles River Laboratories, CTI Clinical Trial and Consulting Services Inc, and WuXi AppTec.

Wuxi AppTec is a leading company that offers a wide portfolio of R&D and manufacturing services for the pharmaceutical and healthcare industries. It provides integrated end-to-end services through its unique business models, which include preclinical testing & clinical research services, biology discovery, chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), cell & gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), and helping customers improve the productivity of healthcare products via cost-effective & efficient solutions. Founded in 2000, Wuxi AppTec is headquartered in Shanghai, China.

 

Key deliverables of the report:

      Market CAGR during the forecasting years 2022-2028

      Detailed data highlighting key insights, industry components, and market strategies


      Comprehensive information and estimation of the clinical trials support services market revenue growth in Asia-Pacific and its influence on the parent market


      In-depth study of forthcoming trends in consumer behavioral patterns


      A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model


      A wide-ranging study of factors that will challenge the Asia-Pacific clinical trials support services market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET

2.2. KEY INSIGHTS

2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS

2.2.2. INCREASE IN SCREENING TESTS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. PERFORMANCE

2.4.2. EASE OF USE

2.4.3. SECURITY

2.4.4. COST EFFECTIVENESS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1. ACQUISITIONS

2.9.2. PRODUCT LAUNCHES

2.9.3. CONTRACTS & AGREEMENTS

2.9.4. INVESTMENTS & EXPANSIONS

2.10. MARKET DRIVERS

2.10.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS

2.10.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE

2.11. MARKET CHALLENGES

2.11.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK

2.11.2. USE OF OPEN-SOURCE SOFTWARE

2.12. MARKET OPPORTUNITIES

2.12.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS

2.12.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH

2.12.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET

3. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE

3.1. PHASE I

3.2. PHASE II

3.3. PHASE III

3.4. PHASE IV

4. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE

4.1. CLINICAL TRIAL SITE MANAGEMENT

4.2. ADMINISTRATIVE SERVICES

4.3. PATIENT RECRUITMENT MANAGEMENT

4.4. REGULATORY SERVICES

4.5. DATA MANAGEMENT

4.6. OTHER SERVICES

5. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR

5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES

5.2. MEDICAL DEVICE COMPANIES

5.3. OTHER SPONSORS

6. ASIA-PACIFIC  CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK

6.1. CHINA

6.2. JAPAN

6.3. INDIA

6.4. SOUTH KOREA

6.5. ASEAN COUNTRIES

6.6. AUSTRALIA & NEW ZEALAND

6.7. REST OF ASIA-PACIFIC

7. COMPETITIVE LANDSCAPE

7.1. IQVIA

7.2. PAREXEL

7.3. ICON PLC

7.4. SYNEOS HEALTH

7.5. LABCORP DRUG DEVELOPMENT

7.6. CLINIPACE

7.7. KCR

7.8. CHARLES RIVER LABORATORIES

7.9. MEDPACE

7.10. ALCURA

7.11. PSI CRO

7.12. WORLDWIDE CLINICAL TRIALS

7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC

7.14. WUXI APPTEC

7.15. ADVANCED CLINICAL

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: LIST OF COLLABORATIONS

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF PRODUCT LAUNCHES

TABLE 7: LIST OF CONTRACTS & AGREEMENTS

TABLE 8: LIST OF INVESTMENTS & BUSINESS EXPANSIONS

TABLE 9: LIST OF PANDEMIC OUTBREAKS

TABLE 10: LIST OF OPEN-SOURCE SOFTWARE

TABLE 11: LAUNCH OF MEDICAL DRUGS

TABLE 12: PROMISING ACQUISITIONS IN THE MARKET

TABLE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)

TABLE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)

TABLE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)

FIGURE 5: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)

FIGURE 6: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)

FIGURE 10: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)

FIGURE 17: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 21: CHINA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 22: JAPAN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 23: INDIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 24: SOUTH KOREA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 25: ASEAN COUNTRIES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 26: AUSTRALIA & NEW ZEALAND CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 27: REST OF ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;